Utilizing Engineered E. Coli as an Asymmetric Reducing Biocatalyst Towards Serotonin Reuptake Inhibitors

Document Type

Presentation

Presentation Date

1-1-2007

Abstract or Description

This presentation was given at the ACS National Meeting.

Sponsorship/Conference/Institution

ACS National Meeting

Location

Boston, MA

This document is currently not available here.

Share

COinS